Tag: Imperagen
-
Imperagen raises £5M seed round to accelerate AI-driven enzyme engineering
Manchester techbio Imperagenhas closed a £5 million seed funding round led by PXN Ventures with participation from Imperagen’s existing investors IQ Capital and Northern Gritstone. Established in 2021 by researchers from the Manchester Institute of Biotechnology, Imperagen is focused on accelerating the process of enzyme engineering. Serving diverse markets, from pharmaceutical manufacturing and life sciences read more
Written by
